Physician profile
Rajesh B Vrushab
NPI 1366405268
$21,446.39
in general payments reported to CMS, 2019-2025
49 companies · $4,443 in 2025
The $4,443 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,893 · 2020: $2,550 · 2021: $2,825 · 2022: $3,556 · 2023: $2,411 · 2024: $3,768 · 2025: $4,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,283 · Travel and Lodging: $2,329 · Education: $10.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,283.11 |
| Travel and Lodging | $2,328.75 |
| Education | $10.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,282.60 | 2019-2025 | Gallant, Aveir, Assurity |
| Medtronic, INC. | $2,979.23 | 2022-2025 | Symplicity G3, Azure Xt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $1,239.93 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $869.35 | 2019-2025 | Farxiga |
| Biosense Webster, INC. | $749.88 | 2023-2025 | Carto 3, Nuvision Ice Catheter, Na |
| Amgen INC. | $636.42 | 2019-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $603.11 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $601.40 | 2019-2025 | Lifevest |
| Pfizer INC. | $565.13 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $536.41 | 2021-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $516.67 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $435.58 | 2019-2022 | |
| Boston Scientific Corporation | $410.09 | 2023-2025 | Farapulse, Bodyguardian, Watchman Flx |
| Esperion Therapeutics, INC. | $408.63 | 2020-2024 | Nexletol |
| Alnylam Pharmaceuticals INC. | $358.36 | 2021-2025 | Onpattro, Amvuttra |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $296.36 | 2019-2024 | |
| Astellas Pharma US INC | $229.53 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $205.02 | 2019-2025 | Camzyos, Eliquis |
| Philips North America LLC | $189.86 | 2020-2025 | (Ck7) Extended Holter, Extended Holter, Lm Undivided |
| Novo Nordisk INC | $181.38 | 2021-2025 | Wegovy, Ozempic |
| Lundbeck LLC | $120.36 | 2019-2021 | |
| Bardy Diagnostics, INC. | $95.00 | 2019-2020 | |
| Scpharmaceuticals INC. | $87.00 | 2024-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $79.74 | 2021-2023 | Arcalyst |
| Edwards Lifesciences Corporation | $72.11 | 2019-2025 | Sapien 3 Ultra Resilia |
| Inspire Medical Systems, INC. | $67.96 | 2023-2025 | Inspire |
| Atricure, INC. | $52.15 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $46.94 | 2024-2025 | Opsumit |
| Glaxosmithkline, LLC. | $43.75 | 2025 | Arexvy, Shingrix |
| Gilead Sciences, INC. | $43.14 | 2019 | |
| G Medical Diagnostic Services, INC. | $41.54 | 2022-2023 | Cardiac Monitoring Suite |
| Baxter Healthcare | $39.66 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Vital Connect, INC | $36.42 | 2025 | Vitalpatch Rtm |
| Kestra Medical Technology Services, INC. | $35.61 | 2025 | Assure Wcd |
| Ionis Pharmaceuticals, INC. | $29.95 | 2025 | Tryngolza |
| Penumbra, INC. | $24.69 | 2022 | |
| Terumo Medical Corporation | $22.21 | 2021 | |
| Cardiovascular Systems INC. | $22.13 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $21.87 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $21.54 | 2023 | Inpefa |
| Lantheus Medical Imaging, INC. | $20.69 | 2025 | |
| Stryker Corporation | $20.35 | 2020 | |
| Mannkind Corporation | $19.89 | 2025 | |
| Arbor Pharmaceuticals, INC. | $18.84 | 2021 | |
| Convatec INC. | $18.77 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $13.53 | 2019 | |
| Cardiva Medical, INC. | $12.11 | 2019 | |
| Angiodynamics, INC. | $11.85 | 2022 | |
| Biotronik INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Vrushab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.